Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1453]
News [2223]
Articles [39]
Editorials [5]
Conferences [150]
elearning [0]
Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for...
Prof Davendra Sohal - University of Cincinnati, Cincinnati, USA
Perioperative chemotherapy with mFOLFIRINOX vs gemcitabine/nab-paclitaxel for resectable pancreatic ductal adenocarcinoma ( Prof Davendra Sohal - University of Cincinnati, Cincinnati, USA )
15 Jun 2020
High-dose twice daily thoracic radiotherapy in limited disease small-cell lung...
Prof Bjørn Henning Grønberg - Trondheim University Hospital, Trondheim, Norway
High-dose twice daily thoracic radiotherapy in limited disease small-cell lung cancer ( Prof Bjørn Henning Grønberg - Trondheim University Hospital, Trondheim, Norway )
15 Jun 2020
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation...
Prof Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer ( Prof Thierry Conroy - Institute Cancer De Lorraine, Nancy, France )
12 Jun 2020
AGO DESKTOP III/ENGOT-ov20: Impact of secondary cytoreductive surgery in...
Prof Andreas du Bois - Kliniken Essen Mitte, Essen, Germany
AGO DESKTOP III/ENGOT-ov20: Impact of secondary cytoreductive surgery in recurrent ovarian cancer ( Prof Andreas du Bois - Kliniken Essen Mitte, Essen, Germany )
12 Jun 2020
Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based...
Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy
Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based therapy for patients with stage III colon cancer ( Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy )
12 Jun 2020
PARP inhibitors in prostate cancer: Choices of tests and how to test?
Dr Kim Chi and Dr Alexander Wyatt
PARP inhibitors in prostate cancer: Choices of tests and how to test? ( Dr Kim Chi and Dr Alexander Wyatt )
11 Jun 2020
FORTE trial: Minimal residual disease evaluation in newly diagnosed multiple...
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
FORTE trial: Minimal residual disease evaluation in newly diagnosed multiple myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
11 Jun 2020
COVID-19: Optimising supportive care during active cancer treatment
Dr Paul Cornes - Comparative Outcomes Group, Bristol, UK
COVID-19: Optimising supportive care during active cancer treatment ( Dr Paul Cornes - Comparative Outcomes Group, Bristol, UK )
10 Jun 2020
PARP inhibitors in prostate cancer: Guidelines, who to test and the patient...
Dr Neal Shore and Dr Elena Castro
PARP inhibitors in prostate cancer: Guidelines, who to test and the patient pathway ( Dr Neal Shore and Dr Elena Castro )
5 Jun 2020
Conducting Oncology Clinical Trials in Africa II: ACTC Informational Session
Prof Folakemi Odedina, Prof Ifeoma Okoye and Prof Delva Shamley
Conducting Oncology Clinical Trials in Africa II: ACTC Informational Session ( Prof Folakemi Odedina, Prof Ifeoma Okoye and Prof Delva Shamley )
3 Jun 2020
Conducting Oncology Clinical Trials in Africa II: Practical steps for...
Dr Victoria Olaiya - Synteract, UK
Conducting Oncology Clinical Trials in Africa II: Practical steps for conducting clinical trials in Africa ( Dr Victoria Olaiya - Synteract, UK )
2 Jun 2020
Ensuring quality care for breast cancer patients globally
Dr Didier Verhoeven - University of Antwerp, Antwerp, Belgium
Ensuring quality care for breast cancer patients globally ( Dr Didier Verhoeven - University of Antwerp, Antwerp, Belgium )
1 Jun 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation